IHU Infiny
@ihu-infiny.bsky.social
IHU Infiny - Institut des Maladies Inflammatoires Chroniques de l’Intestin (MICI)
📍Bâtiment IRIS - Hôpitaux de Brabois - CHRU Nancy, Vandoeuvre-lès-Nancy 54547
➡️ https://www.ihu-infiny.fr/
📍Bâtiment IRIS - Hôpitaux de Brabois - CHRU Nancy, Vandoeuvre-lès-Nancy 54547
➡️ https://www.ihu-infiny.fr/
🔬 #TuesdayReading
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
March 25, 2025 at 9:26 AM
🔬 #TuesdayReading
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
March 11, 2025 at 9:40 AM
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
🔬 #TuesdayReading
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
February 11, 2025 at 12:24 PM
🔬 #TuesdayReading
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
🗽IHU Infiny in NY! @chassainglab.bsky.social , Co-Director for basic research at Infiny & Head of the Microbiota-Host Interactions Unit at the @pasteur.fr, visited the Icahn School of Medicine at Mount Sinai, hosted by Prof. Saurabh Mehandru.
🚀 Stay tuned for exciting collaborations ahead.
🚀 Stay tuned for exciting collaborations ahead.
January 27, 2025 at 9:48 AM
🗽IHU Infiny in NY! @chassainglab.bsky.social , Co-Director for basic research at Infiny & Head of the Microbiota-Host Interactions Unit at the @pasteur.fr, visited the Icahn School of Medicine at Mount Sinai, hosted by Prof. Saurabh Mehandru.
🚀 Stay tuned for exciting collaborations ahead.
🚀 Stay tuned for exciting collaborations ahead.
👋 Hello Bluesky!
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
January 24, 2025 at 4:05 PM
👋 Hello Bluesky!
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny